Post-approval studies (Phase 4)UnknownNCT04739215
What this trial is testing
Effects of SGLT2 Inhibition on the Mechanisms of Cardiac Damage in the Diabetic Patient With HFpEF
Who this might be right for
Diabetes Mellitus, Type 2Heart Failure With Preserved Ejection Fraction
Hospital General Universitario Gregorio Marañon 62